Acid Sphingomyelinase Deficiency Therapeutics Market is driven by Gene Therapy Trends
The acid sphingomyelinase deficiency (ASMD) is a rare genetic lysosomal storage disorder caused due to the deficiency of the acid sphingomyelinase enzyme. This deficiency leads …